Comparison of topical timolol gel to oral acetazolamide in the prophylaxis of viscoelastic-induced ocular hypertension after penetrating keratoplasty

Cornea

Volumn 16, Issue 1, 1997, Pages 12-15

  Kanellopoulos, Anastasios John ^a,b   Perry, Henry D ^c   Donnenfeld, Eric D ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Box 58 ^*

Author keywords

Glaucoma; Penetrating keratoplasty; Viscoelastic induced ocular hypertension

Indexed keywords

ACETAZOLAMIDE; TIMOLOL; TIMOLOL MALEATE;

ARTICLE; CELL LOSS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLAUCOMA; HUMAN; INFLAMMATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPTIC NERVE LESION; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VISCOSITY;

EID: 0031024085     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199701000-00003     Document Type: Article

References (21)

1. Berson FG, Patterson MM, Epstein DL. Obstruction of aqueous outflow by sodium hyaluronate in enucleated human eyes. Am J Ophthalmol 1983;95:668-72.
2. Passo MS, Ernest JT, Goldstick GK. Hyaluronate increases intraocular pressure when used in cataract extraction. Br J Ophthalmol 1983;69:572-5.
3. Foulks GN. Glaucoma associated with penetrating keratoplasty. Ophthalmology 1987;94:871-4.
4. Thoft RA, Gordon JM, Dohlman CH. Glaucoma following keratoplasty. Trans Am Acad Ophthalmol Otol 1974;78:352-64.
5. Goldberg DB, Schanzlin DJ, Brown SI. Incidence of increased intraocular pressure after keratoplasty. Am J Ophthalmol 1981;92: 372-7.
6. Karesh JW, Nirankari VS. Factors associated with glaucoma after penetrating keratoplasty. Am J Ophthalmol 1983;96:160-4.
7. Polack FM. Glaucoma and keratoplasty. Cornea 1988;7:67-9.
8. Kirkness CM, Ficker LA. Risk factors for the development of post-keratoplasty glaucoma. Cornea 1992;11:427-32.
9. Simmons RB, Stern RA, Teekhasaenee C, et al. Elevated intraocular pressure following penetrating keratoplasty. Trans Am Ophthal Soc 1990;87:79-93.
10. Olsen RJ, Kaufman AG. A mathematical description of causative factors in prevention of elevated intraocular pressure after keratoplasty. Invest Ophthalmol Vis Sci 1977;16:1085-92.
11. Beebe WE. Management of glaucoma in penetrating keratoplasty patients. Refract Corneal Surg 1991;7:67-9.
12. Hein SR, Keates RH, Weber PA. Elimination of sodium hyaluronate-induced decrease of outflow facility with hyaluronidase. Ophthalmic Surg 1986;17:731-4.
13. Balazs EA. Sodium hyaluronate in visco surgery. In: Miller D, Stegmann R, eds. Healon: sodium hyaluronate: a guide to its use in ophthalmic surgery. New York: Wiley, 1983:5-28.
14. Morgan RK, Skuta GL. Viscoelastic-related glaucoma. Semin Ophthalmol 1994;9:229-34.
15. Schubert HD, Denlinger JL, Balazs EA. Exogenous sodium hyaluronate in the anterior chamber of the owl monkey and its effect on intraocular pressure. Exp Eye Res 1984;39:137-52.
16. Liesegang TJ. Viscoelastic substitutes in ophthalmology. Surv Ophthalmol 1990;34:268-93.
17. Burke S, Sugar J, Farber MD. Comparison of the effects of two viscoelastic agents Healon and Viscoat. Postoperative intraocular pressure after penetrating keratoplasty. Ophthalmic Surg 1990;21: 821-6.
18. Lane SS, Naylor DW, Kullerstrand LJ, et al. Prospective comparison of the effects of Occucoat, Viscoat and Healon on intraocular pressure and endothelial cell loss. J Cataract Refract Surg 1991; 17:21-6.
19. Nelson WL, Fraunfelder FT, Sills JM, et al. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution. Am J Ophthalmol 1986;102:606-11.
20. Fraunfelder FT, Meyer M, Bodoy GE, et al. Hematologic reactions to carbonic anhydrase inhibitors. Am J Ophthalmol 1985;100:79-81.
21. Chien AM, Schmidt CM, Cohen EJ, et al. Glaucoma in the immediate postoperative period after penetrating keratoplasty. Am J Ophthalmol 1993;115:711-4.